The effect of fampiridine on optic nerve imaging in patients with Anterior Ischemic Optic neuropathy

Phase 1

• Conditions: Anterior Ischemic Optic neuropathy.; Ischemic optic neuropathy; H47.01

• Registration Number: IRCT20151123025202N35
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with anterior ischemic optic neuropathy
Consent to participate in the study
At least 3 months have passed since the onset of symptoms

Exclusion Criteria

Pregnancy
History of seizures
Renal failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acuity Visual. Timepoint: Pre treatment and 12 weeks post treatment. Method of measurement: Using ETDRS chart.;Field of vision. Timepoint: Pre treatment and 12 weeks post treatment. Method of measurement: Using automatic perimetry device.

Secondary Outcome Measures

Name	Time	Method
Change inthickness of nerve cells. Timepoint: Pre treatment and 12 weeks post treatment. Method of measurement: Using Peripapillary-OCT.